Cullinan Therapeutics Inc
(NAS:CGEM)
$
16.665
-0.115 (-0.69%)
Market Cap: 960.47 Mil
Enterprise Value: 535.82 Mil
PE Ratio: 0
PB Ratio: 1.69
GF Score: 30/100 Cullinan Therapeutics Inc (CGEM) Transcripts
- Cullinan Oncology Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Cullinan Oncology Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Cullinan Oncology Inc at Stifel Targeted Oncology Days (Virtual) TranscriptApr 26, 2023
- Cullinan Oncology Inc To Discuss About Licensing Agreement with Harbour Biomed TranscriptFeb 14, 2023
- Cullinan Oncology Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Cullinan Oncology Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Taiho To Acquire Cullinan Oncology's Subsidiary, Cullinan Pearl - M&A Call TranscriptMay 12, 2022
- Cullinan Oncology Inc at Needham Healthcare Conference (Virtual) TranscriptApr 13, 2022
- Cullinan Oncology Inc To Host CLN-081 Regulatory Update Webinar TranscriptMar 28, 2022
- Cullinan Oncology Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Cullinan Oncology Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Cullinan Oncology Inc To Provide CLN-081 Clinical Update Webinar Call TranscriptDec 16, 2021
- Cullinan Oncology Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Cullinan Oncology Inc Pearl Clinical Update Call TranscriptJun 04, 2021
- 1